what are the glp-1 agonists Receptor and Research to Treat Overeating and Substance Use Disorders What is GLP-1 and Its
Description
It could also be expected to increase compliance with adjunctive treatments such as behavioral and motivational therapy. Le Roux said the findings need to be validated through randomized controlled trials, especially a trial enrolling adults with alcohol use disorder

Support includes preclinical binge eating models showing efficacy of GLP-1 and analogues, evidence of altered GLP-1 levels in BED/BN, preliminary human data with abnormal eating

It is reported that the molecule is designed by conjugating a fully humanized anti-GIP receptor monoclonal antibody with a GLP-1 analog peptide segment via an amino acid linker, forming a drug candidate with a dual-action mechanism

Smaller companies are especially struggling
